Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center
Publication
, Journal Article
Babi, MA; Dodds, J; Gonzales, LF; Zomorodi, A; Cobb, MI-PH; Brown, B; Smith, T; forrest, H; Graffagnino, C
Published in: CEREBROVASCULAR DISEASES
January 1, 2016
Duke Scholars
Published In
CEREBROVASCULAR DISEASES
EISSN
1421-9786
ISSN
1015-9770
Publication Date
January 1, 2016
Volume
41
Start / End Page
147 / 147
Publisher
KARGER
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Babi, M. A., Dodds, J., Gonzales, L. F., Zomorodi, A., Cobb, M.-P., Brown, B., … Graffagnino, C. (2016). Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center. CEREBROVASCULAR DISEASES, 41, 147–147.
Babi, M. A., J. Dodds, L. F. Gonzales, A. Zomorodi, M In-Ping Huang Cobb, B. Brown, T. Smith, H. forrest, and C. Graffagnino. “Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center.” CEREBROVASCULAR DISEASES 41 (January 1, 2016): 147–147.
Babi MA, Dodds J, Gonzales LF, Zomorodi A, Cobb MI-PH, Brown B, et al. Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center. CEREBROVASCULAR DISEASES. 2016 Jan 1;41:147–147.
Babi, M. A., et al. “Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center.” CEREBROVASCULAR DISEASES, vol. 41, KARGER, Jan. 2016, pp. 147–147.
Babi MA, Dodds J, Gonzales LF, Zomorodi A, Cobb MI-PH, Brown B, Smith T, forrest H, Graffagnino C. Dual anti-platelet use following combination systemic tbrombolytics and endovascular reperfusion therapies does not increase risk of intracranial hemorrhage: experience from a large academic medical center. CEREBROVASCULAR DISEASES. KARGER; 2016 Jan 1;41:147–147.
Published In
CEREBROVASCULAR DISEASES
EISSN
1421-9786
ISSN
1015-9770
Publication Date
January 1, 2016
Volume
41
Start / End Page
147 / 147
Publisher
KARGER
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences